---
title: "Publications"
---

Full publication list available on [Google Scholar](https://scholar.google.ca/citations?user=iWPPB7AAAAAJ&hl) and [PubMed](https://pubmed.ncbi.nlm.nih.gov/?term=richer+l&sort=date).

---

### 2026

Bertagnolli J, Dukelow SP, Smith DJ, et al. The Clinical Utility of a Novel Multimodal Assessment Battery for Acute Sport-Related Concussion. *Clin J Sport Med*. 2026. [DOI](https://doi.org/10.1097/JSM.0000000000001402)

### 2025

Balcom EF, Mccombe JA, Kate MP, et al. Inequities in the Use of Disease-Modifying Therapy Among Adults Living with Multiple Sclerosis in Urban and Rural Areas in Alberta, Canada. *Neurology*. 2025;104(3):e210251. [DOI](https://doi.org/10.1212/wnl.0000000000210251)

McCombe JA, Smyth P, Kate M, et al. Healthcare Cost of Multiple Sclerosis and in Relation to Disability Level in Alberta. *Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques*. 2025;52(3):399-410. [DOI](https://doi.org/10.1017/cjn.2024.288)

Nguyen PU, Luu H, So H, et al. The Healthcare Cost of Migraine: A Retrospective Cohort Study from Alberta, Canada. *Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques*. 2025. [DOI](https://doi.org/10.1017/cjn.2025.40)

Satkunam L, Dukelow SP, Yu J, et al. Poststroke Care Pathways and Spasticity Treatment: A Retrospective Study in Alberta. *Can J Neurol Sci*. 2025;52(1):75-84. [DOI](https://doi.org/10.1017/cjn.2024.42)

Sicard V, Irani T, Ledoux A, et al. Prevalence of Orthostatic Autonomic Dysregulation in Pediatric Concussion. *JAMA Network Open*. 2025;8(7):e2522309. [DOI](https://doi.org/10.1001/jamanetworkopen.2025.22309)

### 2024

Balcom EF, McCombe JA, Kate M, et al. Geographical Variation in Medication and Health Resource Use in Multiple Sclerosis. *Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques*. 2024;52(2):1-9. [DOI](https://doi.org/10.1017/cjn.2024.54)

Balcom EF, Smyth P, Kate M, et al. Disease-Modifying Therapy Use and Health Resource Utilisation Associated with Multiple Sclerosis over Time: A Retrospective Cohort Study from Alberta, Canada. *Journal of the Neurological Sciences*. 2024;458:122913. [DOI](https://doi.org/10.1016/j.jns.2024.122913)

Dubois C, Fernandes H, Lin M, et al. Benzodiazepine Use in Medical Cannabis Authorization Adult Patients from 2013 to 2021: Alberta, Canada. *BMC Public Health*. 2024;24(1):859. [DOI](https://doi.org/10.1186/s12889-024-18356-6)

Khoramjoo M, Wang K, Srinivasan K, et al. Plasma Taurine Level Is Linked to Symptom Burden and Clinical Outcomes in Post-COVID Condition. *PLOS ONE*. 2024;19(6):e0304522. [DOI](https://doi.org/10.1371/journal.pone.0304522)

Lau RS, Boesen ME, Richer L, et al. Siloed Mentality, Health System Suboptimization and the Healthcare Symphony: A Canadian Perspective. *Health Research Policy and Systems*. 2024;22(1):87. [DOI](https://doi.org/10.1186/s12961-024-01168-w)

Richer L, Craig W, Linsdell M, et al. Autonomic Cardioregulatory Function Does Not Correlate with Symptom Improvement After Concussion in Children and Adolescents. *Journal of Neurotrauma*. 2024;41(1-2):161-170. [DOI](https://doi.org/10.1089/neu.2023.0113)

Satkunam L, Dukelow SP, Yu J, et al. Poststroke Care Pathways and Spasticity Treatment: A Retrospective Study in Alberta. *Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques*. 2024. [DOI](https://doi.org/10.1017/cjn.2024.42)

Skow R, Foulkes S, Seres P, et al. The Cardiac and Cerebrovascular Response to Lower Body Negative Pressure in Patients with Postural Orthostatic Tachycardia Syndrome. *Physiology*. 2024;39(S1):379. [DOI](https://doi.org/10.1152/physiol.2024.39.s1.379)

Skow RJ, Foulkes SJ, Seres P, et al. Effect of Lower Body Negative Pressure on Cardiac and Cerebral Function in Postural Orthostatic Tachycardia Syndrome: A Pilot MRI Assessment. *Physiological Reports*. 2024;12(6):e15979. [DOI](https://doi.org/10.14814/phy2.15979)

### 2023

Ganesh A, Rosentreter RE, Chen Y, et al. Patient-Reported Outcomes of Neurologic and Neuropsychiatric Symptoms in Mild COVID-19: A Prospective Cohort Study. *Canadian Medical Association Open Access Journal*. 2023;11(4):E696-E705. [DOI](https://doi.org/10.9778/cmajo.20220248)

Mitjà O, Reis G, Boulware DR, et al. Hydroxychloroquine for Treatment of Non‐hospitalized Adults with COVID‐19: A Meta‐analysis of Individual Participant Data of Randomized Trials. *Clinical and Translational Science*. 2023;16(3):524-535. [DOI](https://doi.org/10.1111/cts.13468)

Richer L, Luu H, Martins KJB, et al. Trajectory of Health Care Resources Among Adults Stopping or Reducing Treatment Frequency of Botulinum Toxin for Chronic Migraine Treatment in Alberta, Canada. *Headache: The Journal of Head and Face Pain*. 2023;63(9):1285-1294. [DOI](https://doi.org/10.1111/head.14613)

Richer LP, Tan Q, Butler MG, et al. Evaluation of Autonomic Nervous System Dysfunction in Childhood Obesity and Prader–Willi Syndrome. *International Journal of Molecular Sciences*. 2023;24(9):8013. [DOI](https://doi.org/10.3390/ijms24098013)

Sevcik B, Lobay K, Luu H, et al. Analgesic Use Among Adults with a Trauma-Related Emergency Department Visit: A Retrospective Cohort Study from Alberta, Canada. *Pain and Therapy*. 2023;12(4):1039-1053. [DOI](https://doi.org/10.1007/s40122-023-00521-1)

Stickland MK, Martins KJB, Sharpe H, et al. Medication Use of Canadians with Chronic Obstructive Pulmonary Disease: A Cohort Study. *BMJ Open Respiratory Research*. 2023;10(1):e002083. [DOI](https://doi.org/10.1136/bmjresp-2023-002083)

Tsze DS, Kuppermann N, Casper TC, et al. Stratification of Risk for Emergent Intracranial Abnormalities in Children with Headaches: A Pediatric Emergency Care Applied Research Network (PECARN) Study Protocol. *BMJ Open*. 2023;13(11):e079040. [DOI](https://doi.org/10.1136/bmjopen-2023-079040)

Vaughan CG, Ledoux A, Sady MD, et al. Association Between Early Return to School Following Acute Concussion and Symptom Burden at 2 Weeks Postinjury. *JAMA Network Open*. 2023;6(1):e2251839. [DOI](https://doi.org/10.1001/jamanetworkopen.2022.51839)

### 2022

Chue P, Wong KO, Klarenbach S, et al. Health Resource Utilization, Costs, and Community Treatment Order Status Before and After the Initiation of Second-Generation Long Acting-Injectable Antipsychotics in Patients with Schizophrenia in Alberta, Canada. *European Psychiatry*. 2022;65(S1):S117-S117. [DOI](https://doi.org/10.1192/j.eurpsy.2022.326)

Coward S, Martins K, Klarenbach S, et al. A158 Comparing Cortiment® and Prednisone in Ulcerative Colitis: A Population-Based Study of Outcomes. *Journal of the Canadian Association of Gastroenterology*. 2022;5(Suppl 1):33-35. [DOI](https://doi.org/10.1093/jcag/gwab049.157)

Ledoux A-, Tang K, Freedman SB, et al. Early Analgesic Administration and Headache Presence 7 Days Post-Concussion in Children. *Canadian Journal of Emergency Medicine*. 2022;24(8):876-884. [DOI](https://doi.org/10.1007/s43678-022-00367-0)

Lim RK, Rosentreter R, Chen Y, et al. Quality of Life, Respiratory Symptoms, and Health Care Utilization 1 Year Following Outpatient Management of COVID-19: A Prospective Cohort Study. *Scientific Reports*. 2022;12(1):12988. [DOI](https://doi.org/10.1038/s41598-022-17243-7)

Richer L, Wong KO, Martins KJ, et al. Characteristics of Adults with Migraine in Alberta, Canada: A Population-Based Study. *Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques*. 2022;49(2):239-248. [DOI](https://doi.org/10.1017/cjn.2021.68)

Richer LP, Ali S, Johnson DW, et al. A Randomized Trial of Ketorolac and Metoclopramide for Migraine in the Emergency Department. *Headache: The Journal of Head and Face Pain*. 2022;62(6):681-689. [DOI](https://doi.org/10.1111/head.14307)

Ritchie B, Martins KJB, Tran DT, et al. Economic Impact of Self-Administered Subcutaneous Versus Clinic-Administered Intravenous Immunoglobulin G Therapy in Alberta, Canada: A Population-Based Cohort Study. *Allergy, Asthma & Clinical Immunology*. 2022;18(1):99. [DOI](https://doi.org/10.1186/s13223-022-00735-6)

Wong KO, Klarenbach SW, Martins KJB, et al. Health Resource Utilization and Cost Before Versus After Initiation of Second-Generation Long-Acting Injectable Antipsychotics Among Adults with Schizophrenia in Alberta, Canada: A Retrospective, Observational Single-Arm Study. *BMC Psychiatry*. 2022;22(1):444. [DOI](https://doi.org/10.1186/s12888-022-04075-y)

### 2021

Ali S, Hopkin G, Poonai N, et al. A Novel Preference-Informed Complementary Trial (PICT) Design for Clinical Trial Research Influenced by Strong Patient Preferences. *Trials*. 2021;22(1):206. [DOI](https://doi.org/10.1186/s13063-021-05164-1)

Ali S, Hopkin G, Poonai N, et al. Correction To: A Novel Preference-Informed Complementary Trial (PICT) Design for Clinical Trial Research Influenced by Strong Patient Preferences. *Trials*. 2021;22(1):353. [DOI](https://doi.org/10.1186/s13063-021-05312-7)

Lee C, Lin M, Martins KJB, et al. Opioid Use in Medical Cannabis Authorization Adult Patients from 2013 to 2018: Alberta, Canada. *BMC Public Health*. 2021;21(1):843. [DOI](https://doi.org/10.1186/s12889-021-10867-w)

Ng C, Rapoport A, Rajapakse T, et al. P.122 the Pediatric Neuroirritability Management Protocol at the Stollery Children’s Hospital – Inspired by an Irritable Infant with GM3 Synthase Deficiency. *Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques*. 2021;48(s3):S54-S54. [DOI](https://doi.org/10.1017/cjn.2021.398)

Rajapakse T, Bakal J, Mailo J, et al. B.4 Use of Health Care Resources by Pediatric Headache Patients: A Population-Based Cohort Study in the Province of Alberta. *Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques*. 2021;48(s3):S16-S17. [DOI](https://doi.org/10.1017/cjn.2021.273)

Schwartz I, Boesen ME, Cerchiaro G, et al. Assessing the Efficacy and Safety of Hydroxychloroquine as Outpatient Treatment of COVID-19: A Randomized Controlled Trial. *CMAJ Open*. 2021;9(2):E693-E702. [DOI](https://doi.org/10.9778/cmajo.20210069)

Yaworski AM, Yager JY, Richer L, et al. Improved Care and Management of Paediatric Neurological Patients Evaluated at a Paediatric Rapid Access Neurology Clinic: A Pilot Study. *Journal of Paediatrics and Child Health*. 2021. [DOI](https://doi.org/10.1111/jpc.15352)

### 2020

Ali S, Rajagopal M, Klassen T, et al. Study Protocol for Two Complementary Trials of Non-Steroidal or Opioid Analgesia Use for Children Aged 6 to 17 Years with Musculoskeletal Injuries (the No OUCH Study). *BMJ Open*. 2020;10(6):e035177. [DOI](https://doi.org/10.1136/bmjopen-2019-035177)

Barlow KM, Brooks BL, Esser MJ, et al. Efficacy of Melatonin in Children with Postconcussive Symptoms: A Randomized Clinical Trial. *Pediatrics*. 2020;145(4):e20192812. [DOI](https://doi.org/10.1542/peds.2019-2812)

Raj SR, Guzman JC, Harvey P, et al. Canadian Cardiovascular Society Position Statement on Postural Orthostatic Tachycardia Syndrome (POTS) and Related Disorders of Chronic Orthostatic Intolerance. *Canadian Journal of Cardiology*. 2020;36(3):357-372. [DOI](https://doi.org/10.1016/j.cjca.2019.12.024)

Tsze DS, Cruz AT, Mistry RD, et al. Interobserver Agreement in the Assessment of Clinical Findings in Children with Headaches. *The Journal of Pediatrics*. 2020;221:207-214. [DOI](https://doi.org/10.1016/j.jpeds.2020.02.018)

### 2019

Akpinar I, Ohinmaa A, Thording L, et al. The Costs of Industry-Sponsored Medical Device Clinical Trials in Alberta. *PharmacoEconomics - Open*. 2019;3(4):591-597. [DOI](https://doi.org/10.1007/s41669-019-0137-0)

Brooks BL, Plourde V, Beauchamp MH, et al. Predicting Psychological Distress After Pediatric Concussion. *Journal of Neurotrauma*. 2019;36(5):679-685. [DOI](https://doi.org/10.1089/neu.2018.5792)

Kelly LE, Richer L, Ali S, et al. Innovative Approaches to Investigator-Initiated, Multicentre Paediatric Clinical Trials in Canada. *BMJ Open*. 2019;9(6):e029024. [DOI](https://doi.org/10.1136/bmjopen-2019-029024)

Rajapakse T, Mathieu E, Lindsell M, et al. B.04 Alterations in Brain Structure in Pediatric Migraine. *Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques*. 2019;46(s1):S11-S11. [DOI](https://doi.org/10.1017/cjn.2019.93)

Yeates KO, Tang K, Barrowman N, et al. Derivation and Initial Validation of Clinical Phenotypes of Children Presenting with Concussion Acutely in the Emergency Department: Latent Class Analysis of a Multi-Center, Prospective Cohort, Observational Study. *Journal of Neurotrauma*. 2019;36(11):1758-1767. [DOI](https://doi.org/10.1089/neu.2018.6009)

### 2018

Bresee N, Aglipay M, Dubrovsky AS, et al. No Association Between Metoclopramide Treatment in ED and Reduced Risk of Post-Concussion Headache. *The American Journal of Emergency Medicine*. 2018;36(12). [DOI](https://doi.org/10.1016/j.ajem.2018.04.007)

Orr SL, Richer L, Barrowman N, et al. Oral Dexamethasone for the Prevention of Acute Migraine Recurrence in Pediatric Patients Presenting to the Emergency Department with Migraine. *Cephalalgia Reports*. 2018;1(12):251581631880415-8. [DOI](https://doi.org/10.1177/2515816318804158)

### 2017

Orsso CE, Mackenzie M, Alberga AS, et al. The Use of Magnetic Resonance Imaging to Characterize Abnormal Body Composition Phenotypes in Youth with Prader–Willi Syndrome. *Metabolism*. 2017;69:67-75. [DOI](https://doi.org/10.1016/j.metabol.2017.01.020)

Raun N, Mailo J, Spinelli E, et al. Quantitative Phenotypic and Network Analysis of 1q44 Microdeletion for Microcephaly. *American Journal of Medical Genetics Part A*. 2017;173(4):972-977. [DOI](https://doi.org/10.1002/ajmg.a.38139)

Tran DT, Akpinar I, Fedorak R, et al. The Economic Contribution of Industry-Sponsored Pharmaceutical Clinical Trials. *Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques*. 2017;20(1):407-414. [DOI](https://doi.org/10.18433/j3dh0v)

### 2016

Richer L, Billinghurst L, Linsdell MA, et al. Drugs for the Acute Treatment of Migraine in Children and Adolescents. *Cochrane Database of Systematic Reviews*. 2016;4(4):CD005220. [DOI](https://doi.org/10.1002/14651858.cd005220.pub2)

Zemek R, Barrowman N, Freedman SB, et al. Clinical Risk Score for Persistent Postconcussion Symptoms Among Children with Acute Concussion in the ED. *JAMA*. 2016;315(10):1014-2. [DOI](https://doi.org/10.1001/jama.2016.1203)

### 2015

Hansen G, Joffe AR, Bowman SM, et al. Nonconvulsive Seizures and Status Epilepticus in Pediatric Head Trauma: A National Survey. *SAGE Open Medicine*. 2015;3(0):1-8. [DOI](https://doi.org/10.1177/2050312115573817)

Rowe BH, Richer L Improving Migraine Headache Management in Emergency Departments: The Time Has Come. *Cephalalgia*. 2015;35(4):289-290. [DOI](https://doi.org/10.1177/0333102414539056)

### 2014

Barlow KM, Brooks BL, MacMaster FP, et al. A Double-Blind, Placebo-Controlled Intervention Trial of 3 and 10 Mg Sublingual Melatonin for Post-Concussion Syndrome in Youths (PLAYGAME): Study Protocol for a Randomized Controlled Trial. *Trials*. 2014;15(1):271. [DOI](https://doi.org/10.1186/1745-6215-15-271)

Jacob F, Kanigan A, Richer L, et al. Unilateral Möbius Syndrome: Two Cases and a Review of the Literature. *International Journal of Pediatric Otorhinolaryngology*. 2014;78(8):1228-31. [DOI](https://doi.org/10.1016/j.ijporl.2014.05.036)

Richer L, Craig W, Rowe B Randomized Controlled Trial of Treatment Expectation and Intravenous Fluid in Pediatric Migraine. *Headache: The Journal of Head and Face Pain*. 2014;54(9):1496-1505. [DOI](https://doi.org/10.1111/head.12443)

VanderPluym J, Richer L Tic Versus TAC: Differentiating the Neuralgias (trigeminal Neuralgia) from the Cephalalgias (SUNCT and SUNA). *Current Pain and Headache Reports*. 2014;19(2):473. [DOI](https://doi.org/10.1007/s11916-014-0473-9)

### 2013

Scott O, Richer L, Forbes K, et al. Anti–N-Methyl-D-Aspartate (NMDA) Receptor Encephalitis. *Journal of Child Neurology*. 2013;29(5):691-694. [DOI](https://doi.org/10.1177/0883073813501875)

Zemek R, Osmond MH, Barrowman N, et al. Predicting and Preventing Postconcussive Problems in Paediatrics (5P) Study: Protocol for a Prospective Multicentre Clinical Prediction Rule Derivation Study in Children with Concussion. *BMJ Open*. 2013;3(8):e003550. [DOI](https://doi.org/10.1136/bmjopen-2013-003550)

### 2012

Steenweg ME, Vanderver A, Ceulemans B, et al. Novel Infantile-Onset Leukoencephalopathy with High Lactate Level and Slow Improvement. *Archives of Neurology*. 2012;69(6):718-22. [DOI](https://doi.org/10.1001/archneurol.2011.1048)

### 2011

Haqq AM, DeLorey DS, Sharma AM, et al. Autonomic Nervous System Dysfunction in Obesity and Prader–Willi Syndrome: Current Evidence and Implications for Future Obesity Therapies. *Clinical Obesity*. 2011;1(4‐6):175-183. [DOI](https://doi.org/10.1111/j.1758-8111.2012.00032.x)

Richer LP, Dower NA, Leonard N, et al. Familial Recurrence of Cerebral Palsy with Multiple Risk Factors. *Case Reports in Pediatrics*. 2011;2011(731):307857-5. [DOI](https://doi.org/10.1155/2011/307857)

### 2010

Richer LP, Laycock K, Millar K, et al. Treatment of Children with Migraine in Emergency Departments: National Practice Variation Study. *Pediatrics*. 2010;126(1):e150-5. [DOI](https://doi.org/10.1542/peds.2009-2337)

### 2008

Ramaswamy V, Mehta V, Bauman M, et al. Decompressive Hemicraniectomy in Children with Severe Ischemic Stroke and Life-Threatening Cerebral Edema. *Journal of Child Neurology*. 2008;23(8):889-94. [DOI](https://doi.org/10.1177/0883073808314960)

Richer LP, Laycock K, Rowe B, et al. ED Migraine II: A National Practice Variation Study of Migraine Treatment in Canadian Pediatric Emergency Departments. 2008;48:s28.

### 2007

Richer L, Graham L, Klassen T, et al. Emergency Department Management of Acute Migraine in Children in Canada: A Practice Variation Study. *Headache: The Journal of Head and Face Pain*. 2007;47(5):703-10. [DOI](https://doi.org/10.1111/j.1526-4610.2007.00782.x)

### 2006

Huntsman RJ, Sinclair DB, Richer LP Tuberous Sclerosis with Open Lipped Schizencephaly. *Pediatric Neurology*. 2006;34(3):231-234. [DOI](https://doi.org/10.1016/j.pediatrneurol.2005.08.012)

### 2005

LawrenceRicher Ibuprofen or Acetaminophen for the Acute Treatment of Migraine in Children: A Double-Blind, Randomized, Placebo-Controlled, Crossover Study. 2005.

LawrenceRicher Intranasal Sumatriptan for the Acute Treatment of Migraine in Children. 2005.

Ramaswamy V, Sinclair DB, Wheatley BM, et al. Epilepsia Partialis Continua: Acute Disseminated Encephalomyelitis or Rasmussen’s Encephalitis?. *Pediatric Neurology*. 2005;32(5):341-345. [DOI](https://doi.org/10.1016/j.pediatrneurol.2005.01.001)

Richer LP, Sinclair DB, Bhargava R Neuroimaging Features of Acute Disseminated Encephalomyelitis in Childhood. *Pediatric Neurology*. 2005;32(1):30-6. [DOI](https://doi.org/10.1016/j.pediatrneurol.2004.07.004)

### 2004

Richer LP Childhood Headache (book Review). 2004.

### 2003

Moyse R, Richer L, Vaudry W An Adolescent with a Progressive Movement Disorder. *Clinical Infectious Diseases*. 2003;36(9):1155-6- 1195-6. [DOI](https://doi.org/10.1086/368316)

### 2002

Richer LP, Shevell MI, Rosenblatt BR Epileptiform Abnormalities in Children with Attention-Deficit-Hyperactivity Disorder. *Pediatric Neurology*. 2002;26(2):125-9. [DOI](https://doi.org/10.1016/s0887-8994(01)00370-8)

Richer LP, Shevell MI, Stewart J, et al. Pediatric Meralgia Paresthetica. *Pediatric Neurology*. 2002;26(4):321-3. [DOI](https://doi.org/10.1016/s0887-8994(01)00397-6)

### 2001

Richer LP, Shevell MI, Miller SP Diagnostic Profile of Neonatal Hypotonia: An 11-Year Study. *Pediatric Neurology*. 2001;25(1):32-7. [DOI](https://doi.org/10.1016/s0887-8994(01)00277-6)
